Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.77 |
| ▸ | L3MBTL1 | Q9Y468 | 6/20 | 0.41 |
| ▸ | MEN1 | O00255 | 4/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.41 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.38 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | KCNJ5 | P48544 | 1/20 | 0.36 |
| ▸ | KCNJ3 | P48549 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4408008 | 0.92 | ATM (0.67) | ATML3MBTL1MEN1KMT2ATLR9 | |
| SCHEMBL13654821 | 0.90 | ATM (0.65) | ATML3MBTL1MEN1KMT2ATLR9 | |
| SCHEMBL13925420 | 0.89 | ATM (0.67) | ATML3MBTL1MEN1KMT2ATLR9 | |
| SCHEMBL18723495 | 0.87 | ATM (0.61) | ATML3MBTL1MEN1KMT2ATLR9 | |
| SCHEMBL18270526 | 0.83 | ATM (0.63) | ATMMEN1KMT2ANPC1RAB9A | |
| SCHEMBL13914147 | 0.81 | ATM (0.58) | ATMMEN1KMT2ARAB9ARXFP1 | |
| SCHEMBL21166972 | 0.79 | ATM (0.51) | ATML3MBTL1MEN1KMT2ATLR9 | |
| SCHEMBL29431109 | 0.79 | ATM (0.51) | ATML3MBTL1RXFP1GAAALDH1A1 | |
| SCHEMBL21915051 | 0.79 | ATM (0.51) | ATML3MBTL1RXFP1GAAALDH1A1 | |
| SCHEMBL25752526 | 0.78 | ATM (0.50) | ATML3MBTL1MEN1KMT2ATLR9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 268 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1335637-B1 | Making electroluminescent display devices | GLOBAL OLED TECHNOLOGY LLC (US) | 2017-08-23 | — | — | EP | disclosed |
| US-9666826-B2 | Electroluminescent device including an anthracene derivative | GLOBAL OLED TECHNOLOGY LLC (US) | 2017-05-30 | — | — | US | disclosed |
| US-9666826-B2 | Electroluminescent device including an anthracene derivative | GLOBAL OLED TECHNOLOGY LLC (US) | 2017-05-30 | — | — | US | disclosed |
| US-20150221880-A1 | ELECTROLUMINESCENT DEVICE WITH QUINAZOLINE COMPLEX EMITTER | GLOBAL OLED TECHNOLOGY LLC (US) | 2015-08-06 | — | — | US | disclosed |
| US-20150221880-A1 | ELECTROLUMINESCENT DEVICE WITH QUINAZOLINE COMPLEX EMITTER | GLOBAL OLED TECHNOLOGY LLC (US) | 2015-08-06 | — | — | US | disclosed |
| US-9040170-B2 | Electroluminescent device with quinazoline complex emitter | GLOBAL OLED TECHNOLOGY LLC (US) | 2015-05-26 | — | — | US | disclosed |
| US-9040170-B2 | Electroluminescent device with quinazoline complex emitter | GLOBAL OLED TECHNOLOGY LLC (US) | 2015-05-26 | — | — | US | disclosed |
| US-8956738-B2 | Organic element for low voltage electroluminescent devices | GLOBAL OLED TECHNOLOGY LLC (US) | 2015-02-17 | — | — | US | disclosed |
| US-8900722-B2 | OLED device employing alkali metal cluster compounds | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-12-02 | — | — | US | disclosed |
| US-8900722-B2 | OLED device employing alkali metal cluster compounds | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-12-02 | — | — | US | disclosed |
| US-7169484-B2 | Process for forming a composite including an aluminum trisquinoline complex | EASTMAN KODAK COMPANY (US) | 2007-01-30 | — | — | US | disclosed |
| WO-2007005227-A1 | ELECTROLUMINESCENT DEVICES CONTAINING BENZIDINE DERIVATIVES | EASTMAN KODAK COMPANY (US) | 2007-01-11 | — | — | WO | disclosed |
| US-20070003784-A1 | Electroluminescent device containing borondiketonate emitter | EASTMAN KODAK COMPANY | 2007-01-04 | — | — | US | disclosed |
| US-20070003784-A1 | Electroluminescent device containing borondiketonate emitter | EASTMAN KODAK COMPANY | 2007-01-04 | — | — | US | disclosed |
| US-20070003786-A1 | Electroluminescent devices with nitrogen bidentate ligands | EASTMAN KODAK COMPANY | 2007-01-04 | — | — | US | disclosed |
| US-20070003786-A1 | Electroluminescent devices with nitrogen bidentate ligands | EASTMAN KODAK COMPANY | 2007-01-04 | — | — | US | disclosed |
| US-20070003785-A1 | Electroluminescent devices containing benzidine derivatives | EASTMAN KODAK COMPANY | 2007-01-04 | — | — | US | disclosed |
| US-20070003785-A1 | Electroluminescent devices containing benzidine derivatives | EASTMAN KODAK COMPANY | 2007-01-04 | — | — | US | disclosed |
| US-20070001587-A1 | White light tandem OLED display with filters | EASTMAN KODAK COMPANY | 2007-01-04 | — | — | US | disclosed |
| US-20070001587-A1 | White light tandem OLED display with filters | EASTMAN KODAK COMPANY | 2007-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150221880-A1 | ELECTROLUMINESCENT DEVICE WITH QUINAZOLINE COMPLEX EMITTER | OCIAD2, OCIAD1, JUND | ATM 2042/4885L3MBTL1 2011/4885MEN1 3793/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.